Essex Bio-Technology Ltd (Essex or the Group, HKG: 1061) today announced that the first patient in the United States (US)…
Browsing: Clinical Trials
Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the Asia Pacific Cell & Gene Therapy Clinical…
Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important…
Expands Drug Development and FDA Regulatory Expertise Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR…
HighTide Therapeutics Inc. (HighTide), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today…
More than 40 biotech clients are now taking advantage of Avance Clinical’s GlobalReady program which delivers streamlined clinical development from…
Global biopharmaceutical company focusing on metabolic and digestive diseases Proceeds to fund clinical and business development HighTide Therapeutics Inc. (HighTide),…
Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor at Biotech Showcase 2023. Novotech CEO…
Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost…
Verseon is delighted to announce that the European Journal of Medicinal Chemistry has published a paper (www.sciencedirect.com/science/article/abs/pii/S0223523422007577) describing the company’s groundbreaking…
Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sullivan Company of the Year Award…
Novotech, the leading Asia Pacific biotech specialist CRO, is sponsoring BioCentury-BayHelix East-West Summit 2022, and Novotech’s Chief Commercial Officer Barry…
Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest China biotech landscape analysis with expert…
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital…
Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar for biotechs considering the clinical research…
Novotech, the leading Asia Pacific biotech specialist CRO, has again received Best Workplace certification by the leading workplace culture organization…
Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global CROs as a finalist in the…
Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier’s Export Awards – International…
Successful In Vivo Testing Clears the Way for First Human Trial in Near Future HONG KONG, Sept 22, 2022 – (ACN Newswire) – Agilis…
Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene Therapy Clinical Trials award at…